Acadian Asset Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.39M | Buy |
1,163,785
+233,556
| +25% | +$880K | 0.01% | 621 |
|
2025
Q1 | $4.21M | Buy |
930,229
+437,536
| +89% | +$1.98M | 0.01% | 551 |
|
2024
Q4 | $3.48M | Buy |
492,693
+15,426
| +3% | +$109K | 0.01% | 621 |
|
2024
Q3 | $3.88M | Sell |
477,267
-256,990
| -35% | -$2.09M | 0.01% | 565 |
|
2024
Q2 | $4.69M | Buy |
734,257
+9,697
| +1% | +$61.9K | 0.01% | 517 |
|
2024
Q1 | $5.45M | Buy |
724,560
+200,494
| +38% | +$1.51M | 0.02% | 449 |
|
2023
Q4 | $4.85M | Buy |
524,066
+358,670
| +217% | +$3.32M | 0.02% | 467 |
|
2023
Q3 | $1.67M | Sell |
165,396
-157,603
| -49% | -$1.59M | 0.01% | 739 |
|
2023
Q2 | $4.03M | Buy |
322,999
+184,175
| +133% | +$2.3M | 0.02% | 506 |
|
2023
Q1 | $1.62M | Buy |
138,824
+59,435
| +75% | +$691K | 0.01% | 767 |
|
2022
Q4 | $842K | Buy |
+79,389
| New | +$842K | ﹤0.01% | 892 |
|